Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant Recipients

Published:2022-12 Issue:12 Volume:7 Page:2617-2629
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Berger Bastien,Hazzan Marc,Kamar Nassim,Francois Hélène,Matignon Marie,Greze Clarisse,Gatault Philippe,Frimat Luc,Westeel Pierre F.,Goutaudier Valentin,Snanoudj Renaud,Colosio Charlotte,Sicard Antoine,Bertrand Dominique,Mousson Christiane,Bamoulid Jamal,Thierry Antoine,Anglicheau Dany,Couzi Lionel,Chemouny Jonathan M.,Duveau Agnes,Moal Valerie,Le Meur Yannick,Blancho Gilles,Tourret Jérôme,Malvezzi Paolo,Mariat Christophe,Rerolle Jean-Philippe,Bouvier Nicolas,Caillard Sophie,Thaunat Olivier

Funder

Etablissement Français du Sang

Fondation pour la Recherche Médicale

Publisher

Elsevier BV

Subject

Nephrology

Reference54 articles.

1. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat Rev Microbiol,2021

2. Characteristics and outcomes of COVID-19 patients during initial peak and resurgence in the Houston metropolitan area;Vahidy;JAMA,2020

3. Main differences between the first and second waves of COVID-19 in Madrid, Spain;Soriano;Int J Infect Dis,2021

4. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020

5. Considerations for diagnostic COVID-19 tests;Vandenberg;Nat Rev Microbiol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and outcomes of hospitalized kidney transplant recipients with COVID-19 infection in China during the Omicron wave: a single-center cohort study;Journal of Zhejiang University-SCIENCE B;2024-06

2. Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose;Microorganisms;2024-04-02

3. Challenges Faced by Solid Organ Transplant Recipients During the COVID-19 Pandemic in France: Historical Insights and Key Takeaways;Transplantation;2024-03-23

4. Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease;Kidney International Reports;2023-07

5. Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG);Nephrology Dialysis Transplantation;2023-03-06